These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7057595)

  • 1. Can "artificial blood' live up to public billing?
    Cowart VS
    JAMA; 1982 Feb; 247(8):1104-5. PubMed ID: 7057595
    [No Abstract]   [Full Text] [Related]  

  • 2. Red cell substitutes: present status.
    Sehgal LR; Sehgal HL; Gould SA; Rosen AL; DeWoskin R; Moss GS
    Indian J Pediatr; 1987; 54(3):403-8. PubMed ID: 3301660
    [No Abstract]   [Full Text] [Related]  

  • 3. Polyhemoglobin and fluorocarbon as blood substitutes.
    Moss GS; Gould SA; Sehgal LR; Rosen AL; Sehgal HL
    Biomater Artif Cells Artif Organs; 1987; 15(2):333-6. PubMed ID: 3447649
    [No Abstract]   [Full Text] [Related]  

  • 4. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services?
    Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experience with Fluosol-DA (20%) in the United States.
    Tremper KK; Levine EM; Waxman K
    Int Anesthesiol Clin; 1985; 23(1):185-97. PubMed ID: 3884514
    [No Abstract]   [Full Text] [Related]  

  • 6. The protective effect of mannitol and perfluorochemicals on hemorrhagic infarction: an experimental study.
    Kagawa S; Koshu K; Yoshimoto T; Suzuki J
    Surg Neurol; 1982 Jan; 17(1):66-70. PubMed ID: 6803373
    [No Abstract]   [Full Text] [Related]  

  • 7. Perfluorochemical emulsion oxygen transport fluids: a clinical review.
    Tremper KK; Anderson ST
    Annu Rev Med; 1985; 36():309-13. PubMed ID: 3888055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the perfluorocarbon Fluosol-DA in coronary angioplasty.
    Kerins DM
    Am J Med Sci; 1994 Mar; 307(3):218-21. PubMed ID: 8160713
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluosol DA-20% in treatment of severe anemia: ongoing studies in 52 patients.
    Spence RK; McCoy S; Costabile J; Norcross ED; Pello M; Alexander J; Atabek U; Wisdom C; Camishion R
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1069. PubMed ID: 1391428
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of hemodilution with dextran, stroma-free hemoglobin solution and fluosol-DA on experimental myocardial ischemia in the dog.
    Biro GP
    Bibl Haematol; 1981; (47):54-69. PubMed ID: 6175307
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular effects of various colloidal solutions during major abdominal surgery.
    Nishimura N; Hiranuma N; Sugi T
    Crit Care Med; 1983 Dec; 11(12):940-2. PubMed ID: 6196154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and clinical application of perfluorochemical artificial blood.
    Ohyanagi H; Saitoh Y
    Int J Artif Organs; 1986 Sep; 9(5):363-8. PubMed ID: 3781670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood substitutes: where do we stand with the fluorocarbon approach?
    Riess JG
    Curr Surg; 1988; 45(5):365-70. PubMed ID: 3073041
    [No Abstract]   [Full Text] [Related]  

  • 14. Artificial blood.
    Urbaniak SJ
    BMJ; 1991 Nov; 303(6814):1348-50. PubMed ID: 1760596
    [No Abstract]   [Full Text] [Related]  

  • 15. Normothermic whole body rinse-out utilizing perfluorochemical(PFC)-containing artificial blood.
    Agishi T; Yamagata K; Kobayashi M; Teraoka S; Honda H; Ota K
    Trans Am Soc Artif Intern Organs; 1984; 30():295-7. PubMed ID: 6533899
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oxygen carriers with fluorocarbon base. An introduction].
    Riess JG
    Rev Fr Transfus Immunohematol; 1986 Dec; 29(6):423-41. PubMed ID: 3296110
    [No Abstract]   [Full Text] [Related]  

  • 17. Initial Canadian experience with artificial blood (Fluosol-DA-20%) in severely anemic patients.
    Stefaniszyn HJ; Wynands JE; Salerno TA
    J Cardiovasc Surg (Torino); 1985; 26(4):337-42. PubMed ID: 4019576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Will Japanese white blood be coursing through our veins? A revolution: the first synthetic blood will soon be commercialized].
    Lecuyer G
    Servir; 1989; 37(5):270-3. PubMed ID: 2516646
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%). Part II: Human cerebral blood flow.
    Nagasawa S; Handa H; Yonekawa Y; Oda Y; Tsuda Y; Yokoyama K
    Neurol Res; 1983; 5(2):19-30. PubMed ID: 6140661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current perspectives on blood substitutes.
    Gould SA; Moss G
    Curr Surg; 1987; 44(4):279-81. PubMed ID: 3665573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.